Andreas Pahl is the founder of Heidelberg Pharma. Professor Andreas Pahl became the Chief Executive Officer of Heidelberg Pharma AG on February 1, 2024.
Professor Andreas Pahl became the Chief Executive Officer of Heidelberg Pharma AG on February 1, 2024. He has been with Heidelberg Pharma since 2012, initially as Head of Research & Development, and joined the Executive Management Board in 2016. He holds a doctorate in chemistry and possesses over 25 years of experience in the pharmaceutical industry, as well as in research and teaching.
Full founder directory · Investor directory · Company funding database · Fundraising library